aTyr Pharma Statistics
Want to see ATYR full AI Analyst Report?
aTyr Pharma (ATYR) Stock Statistics & Valuation Metrics
Total Valuation
aTyr Pharma has a market cap or net worth of $15.23M. The enterprise value is -$8.25M.
- Market Cap
- $15.23M
- Enterprise Value
- -$8.25M
Share Statistics
aTyr Pharma has 2,452,186 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 2,452,186
- Owned by Insiders
- 2.55%
- Owned by Institutions
- 19.11%
Financial Efficiency
aTyr Pharma’s return on equity (ROE) is -1.10 and return on invested capital (ROIC) is -97.86%.
- Return on Equity (ROE)
- -1.10
- Return on Assets (ROA)
- -0.80
- Return on Invested Capital (ROIC)
- -97.86%
- Return on Capital Employed (ROCE)
- -1.00
- Revenue Per Employee
- 3,275.862
- Profits Per Employee
- -1.28M
- Employee Count
- 58
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of aTyr Pharma is -0.28. aTyr Pharma’s PEG ratio is -0.01.
- PE Ratio
- -0.28
- PS Ratio
- 0.00
- PB Ratio
- 0.44
- Price to FCF
- -0.34
- Price to Operating Cash Flow
- -0.34
- PEG Ratio
- -0.01
Income Statement
In the last 12 months, aTyr Pharma had revenue of 190.00K and earned -74.12M in profits. Earnings per share was -32.00.
- Revenue
- 190.00K
- Gross Profit
- -1.36M
- Operating Income
- -77.63M
- Pretax Income
- -74.12M
- Net Income
- -74.12M
- EBITDA
- -72.56M
- Earnings Per Share (EPS)
- -32.00
Cash Flow
In the last 12 months, operating cash flow was -43.58M and capital expenditures -287,000, giving a free cash flow of -43.86M billion.
- Operating Cash Flow
- -43.58M
- Free Cash Flow
- -43.86M
- Free Cash Flow per Share
- -17.85
Dividends & Yields
aTyr Pharma pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -296.14%
- Earnings Yield
- -359.37%
Stock Price Statistics
- Beta
- 1.15
- 52-Week Price Change
- -78.61%
- 50-Day Moving Average
- 10.88
- 200-Day Moving Average
- 23.02
- Relative Strength Index (RSI)
- 37.31
- Average Volume (3m)
- 109.55K
Important Dates
aTyr Pharma upcoming earnings date is Mar 18, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 05, 2026
- Next Earnings Date
- Mar 18, 2027
- Ex-Dividend Date
- ―
Financial Position
aTyr Pharma as a current ratio of 5.30, with Debt / Equity ratio of 17.83%
- Current Ratio
- 5.30
- Quick Ratio
- 5.30
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -0.02
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, aTyr Pharma has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
aTyr Pharma EV to EBITDA ratio is -0.24, with an EV/FCF ratio of -0.29.
- EV to Sales
- 0.00
- EV to EBITDA
- -0.24
- EV to Free Cash Flow
- -0.29
- EV to Operating Cash Flow
- -0.29
Balance Sheet
aTyr Pharma has $48.75M in cash and marketable securities with $10.92M in debt, giving a net cash position of $37.83M billion.
- Cash & Marketable Securities
- $48.75M
- Total Debt
- $10.92M
- Net Cash
- $37.83M
- Net Cash Per Share
- $15.43
- Tangible Book Value Per Share
- $13.76
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for aTyr Pharma is $5.00, which is 11.43% higher than the current price. The consensus rating is Neutral
- Price Target
- $5.00
- Price Target Upside
- 18.10% Downside
- Analyst Consensus
- Neutral
- Analyst Count
- 5
- Revenue Growth Forecast
- -100.00%
- EPS Growth Forecast
- 34.89%
Scores
- Smart Score
- ―
- AI Score
- 45
